Kymera Investor Day Presentation Deck slide image

Kymera Investor Day Presentation Deck

Kymera has Engaged a Broadly Expressed Protein in Only One Cell Type Using a Tissue Selective E3 Ligase Protein Kymera Has Identified an E3 Ligase that is Expressed Almost Exclusively in One Cell Population CRBN Ligase X Biological Replicates Protein Expression Profile (Proprietary E3 Atlas) Target Cells 1 23 Cell #1 1 2 3 Cell #2 Log 10 Tox Cell Types 1 2 3 Cell #3 Concentration Estimate [nM] KYMERA ©2021 KYMERA THERAPEUTICS, INC. 1 2 3 Cell #4 1 2 1 2 3 Cell #5 Ligand Identification and Optimization Small Molecule Ligand Bound to a Tissue-selective E3 Ligase KYMERA R&D DAY - December 16th, 2021 Lead Compound Affinity K = < 1 uM Leads to an Active Ternary Complex with a Protein of Interest Relative Signal 1.0 0.5 0.0 AUC 1.133 Bmax=1109 nM -9 -8 -7 -6 -5 -4 Log[Compound], M PAGE 90
View entire presentation